These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34549835)

  • 21. The Mutational Profile of Unicystic Ameloblastoma.
    Heikinheimo K; Huhtala JM; Thiel A; Kurppa KJ; Heikinheimo H; Kovac M; Kragelund C; Warfvinge G; Dawson H; Elenius K; Ristimäki A; Baumhoer D; Morgan PR
    J Dent Res; 2019 Jan; 98(1):54-60. PubMed ID: 30216733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenoid Ameloblastoma Shares Clinical, Histologic, and Molecular Features With Dentinogenic Ghost Cell Tumor: The Histologic Spectrum of WNT Pathway-Altered Benign Odontogenic Tumors.
    Oh KY; Hong SD; Yoon HJ
    Mod Pathol; 2023 Mar; 36(3):100051. PubMed ID: 36788106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BRAF p.V600E status in epithelial areas of ameloblastoma with different histological aspects: Implications to the clinical practice.
    Sant'Ana MSP; Dos Santos Costa SF; da Silva MP; Martins-Chaves RR; Pereira TDSF; de Oliveira EM; Martínez Pedraza R; de Castro WH; Gomes CC; Gomez RS; Fonseca FP
    J Oral Pathol Med; 2021 May; 50(5):478-484. PubMed ID: 33377543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activating FGFR2-RAS-BRAF mutations in ameloblastoma.
    Brown NA; Rolland D; McHugh JB; Weigelin HC; Zhao L; Lim MS; Elenitoba-Johnson KS; Betz BL
    Clin Cancer Res; 2014 Nov; 20(21):5517-26. PubMed ID: 24993163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection and evaluation of the presence of the BRAF V600E mutation in ameloblastomas in an Indian population.
    Goes CF; Spadigam A; Dhupar A; Carvalho KM; Cota J; Syed S
    Indian J Pathol Microbiol; 2023; 66(2):246-251. PubMed ID: 37077063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unicystic adenoid ameloblastoma: A new variant?
    Martins-Chaves RR; Coura BP; Gomes CC; Fonseca FP; de Castro WH; Gomez RS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Jul; 134(1):e23-e28. PubMed ID: 35153188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [BRAF V600E expression in ameloblastomas, ameloblastic carcinomas and cysts].
    Pei J; Zhang L; Jia YX; Chen WH
    Shanghai Kou Qiang Yi Xue; 2023 Dec; 32(6):630-634. PubMed ID: 38494972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenoid ameloblastoma with dentinoid: A rare hybrid odontogenic tumor.
    Chettiankandy TJ; Sachdev SS; Kende PP; Sardar MA; Saju R
    Indian J Pathol Microbiol; 2024 Apr; 67(2):441-444. PubMed ID: 38391318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenoid ameloblastoma with dentinoid and cellular atypia: a case report and literature review.
    Khalele BAO
    Pathologica; 2017 Dec; 109(4):379-381. PubMed ID: 29449727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRAFV600E mutation in the diagnosis of unicystic ameloblastoma.
    Pereira NB; Pereira KM; Coura BP; Diniz MG; de Castro WH; Gomes CC; Gomez RS
    J Oral Pathol Med; 2016 Nov; 45(10):780-785. PubMed ID: 27084044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcifying Odontogenic Cyst Demonstrates Recurrent WNT Pathway Mutations and So-Called Adenoid Ameloblastoma-Like Histology: Evidence Supporting Its Classification as a Neoplasm.
    Oh KY; Kim JH; Yoon HJ
    Mod Pathol; 2024 Jun; 37(6):100484. PubMed ID: 38574817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of MDM2 Overexpression in Ameloblastomas with
    Tosios KI; Kalogirou EM; Koutlas IG
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic Profile of Adenomatoid Odontogenic Tumor and Ameloblastoma. A Systematic Review.
    Marín C; Niklander SE; Martínez-Flores R
    Front Oral Health; 2021; 2():767474. PubMed ID: 35048068
    [No Abstract]   [Full Text] [Related]  

  • 34. Discrepancy between immunohistochemistry and sequencing for BRAF V600E in odontogenic tumours: Comparative analysis of two VE1 antibodies.
    Oh KY; Cho SD; Yoon HJ; Lee JI; Hong SD
    J Oral Pathol Med; 2021 Jan; 50(1):85-91. PubMed ID: 32939809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenoid Ameloblastoma Versus Dentinogenic Ghost Cell Tumor.
    Bastos VC; Gomes CC; Gomez RS
    Head Neck Pathol; 2023 Mar; 17(1):275-276. PubMed ID: 36169792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Systematic Review of Adenoid Ameloblastoma: A Newly Recognized Entity.
    de Farias Morais HG; Gonçalo RIC; de Oliveira Costa CS; de Figueiredo Pires H; Mafra RP; de Morais EF; da Costa Miguel MC; de Almeida Freitas R
    Head Neck Pathol; 2023 Sep; 17(3):688-696. PubMed ID: 37540485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ameloblastoma with adenoid features: A series of eight cases.
    Adorno-Farias D; Muniz VRVM; Soares AP; Cury PR; Rabelo RG; Fernández-Ramires R; de Azevedo RA; Dos Santos JN
    Acta Histochem; 2018 Jul; 120(5):468-476. PubMed ID: 29799420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of BRAF V600E mutation in odontogenic tumors by high-performance MALDI-TOF analysis.
    Togni L; Zizzi A; Mazzucchelli R; Santarelli A; Rubini C; Mascitti M
    Int J Oral Sci; 2022 Apr; 14(1):22. PubMed ID: 35468886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An infrequent histopathological subtype of ameloblastoma: Adenoid granular cell ameloblastoma with dentinoid.
    Salehinejad J; Gholami M; Eshghpour M; Mehri T
    Dent Res J (Isfahan); 2016; 13(4):376-8. PubMed ID: 27605998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Molecular Pathology of Odontogenic Tumors: Expanding the Spectrum of MAPK Pathway Driven Tumors.
    Guimarães LM; Coura BP; Gomez RS; Gomes CC
    Front Oral Health; 2021; 2():740788. PubMed ID: 35048058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.